BRPI0817721A2 - Composto, composição farmacêutica, método de tratamento, e, processo para preparação de um composto - Google Patents

Composto, composição farmacêutica, método de tratamento, e, processo para preparação de um composto

Info

Publication number: BRPI0817721A2
Authority: BR; Brazil
Prior art keywords: compound; preparing; treatment; pharmaceutical composition; pharmaceutical
Prior art date: 2007-09-28

Application number

BRPI0817721-0A

Other languages

English (en)

Inventor

Pierette Banker

Eric Eugene Boros

Scott Howard Dickerson

Istvan Kaldor

Cecilia S Koble

Michael Tolar Martin

Steven Meagher Sparks

Stephen Andrew Thomson

Original Assignee

Glaxosmithkline Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-09-28

Filing date

2008-09-25

Publication date

2015-03-31

2008-09-25 Application filed by Glaxosmithkline Llc filed Critical Glaxosmithkline Llc

2015-03-31 Publication of BRPI0817721A2 publication Critical patent/BRPI0817721A2/pt

Links

150000001875 compounds Chemical class 0.000 title 2
238000004519 manufacturing process Methods 0.000 title 1
238000000034 method Methods 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
- C07C275/34—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Diabetes (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Hematology (AREA)
Obesity (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Urology & Nephrology (AREA)
Neurosurgery (AREA)
Endocrinology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Emergency Medicine (AREA)
Vascular Medicine (AREA)
Child & Adolescent Psychology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Indole Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Plural Heterocyclic Compounds (AREA)
Medicinal Preparation (AREA)

BRPI0817721-0A 2007-09-28 2008-09-25 Composto, composição farmacêutica, método de tratamento, e, processo para preparação de um composto BRPI0817721A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US97586207P	2007-09-28	2007-09-28
PCT/US2008/077624 WO2009045830A1 (en)	2007-09-28	2008-09-25	Glycogen phosphorylase inhibitor compound and pharmaceutical composition thereof

Publications (1)

Publication Number	Publication Date
BRPI0817721A2 true BRPI0817721A2 (pt)	2015-03-31

Family

ID=40098462

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0817721-0A BRPI0817721A2 (pt)	2007-09-28	2008-09-25	Composto, composição farmacêutica, método de tratamento, e, processo para preparação de um composto

Country Status (16)

Country	Link
US (1)	US20100305207A1 (pt)
EP (1)	EP2195287A1 (pt)
JP (1)	JP2010540552A (pt)
KR (1)	KR20100087300A (pt)
CN (1)	CN101932557A (pt)
AU (1)	AU2008309003A1 (pt)
BR (1)	BRPI0817721A2 (pt)
CA (1)	CA2701120A1 (pt)
CO (1)	CO6270306A2 (pt)
CR (1)	CR11398A (pt)
DO (1)	DOP2010000075A (pt)
EA (1)	EA201000391A1 (pt)
MA (1)	MA31776B1 (pt)
MX (1)	MX2010003440A (pt)
WO (1)	WO2009045830A1 (pt)
ZA (1)	ZA201002181B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2011107494A1 (de)	2010-03-03	2011-09-09	Sanofi	Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
US8530413B2 (en)	2010-06-21	2013-09-10	Sanofi	Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215387A (en)	2010-07-05	2012-04-16	Sanofi Aventis	Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201215388A (en)	2010-07-05	2012-04-16	Sanofi Sa	(2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201221505A (en)	2010-07-05	2012-06-01	Sanofi Sa	Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
CA2843383A1 (en)	2011-07-29	2013-02-07	Taisho Pharmaceutical Co., Ltd.	Amidine compound or salt thereof
WO2013037390A1 (en)	2011-09-12	2013-03-21	Sanofi	6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2760862B1 (en)	2011-09-27	2015-10-21	Sanofi	6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
US11702384B2 (en)	2019-12-06	2023-07-18	Skc Co., Ltd.	Diisocyanate composition for optical lens and preparation method thereof
WO2021122645A1 (en)	2019-12-20	2021-06-24	Syngenta Crop Protection Ag	Pesticidally active azole-amide compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1996025157A1 (en) *	1995-02-17	1996-08-22	Smithkline Beecham Corporation	Il-8 receptor antagonists
ES2236757T3 (es) *	1995-11-24	2005-07-16	Glaxosmithkline S.P.A.	Derivados de quinolina.
CA2255858C (en) *	1996-05-24	2007-09-11	Neurosearch A/S	Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers
AU2003258491A1 (en) *	2002-09-05	2004-03-29	Neurosearch A/S	Amide derivatives and their use as chloride channel blockers
PT1565429E (pt) *	2002-11-21	2009-07-23	Neurosearch As	Derivados de diaril-ureído e sua utilização médica
CN101098852A (zh) *	2004-11-09	2008-01-02	史密丝克莱恩比彻姆公司	糖原磷酸化酶抑制剂化合物和其药物组合物

2008
- 2008-09-25 CA CA2701120A patent/CA2701120A1/en not_active Abandoned
- 2008-09-25 WO PCT/US2008/077624 patent/WO2009045830A1/en not_active Ceased
- 2008-09-25 EA EA201000391A patent/EA201000391A1/ru unknown
- 2008-09-25 CN CN2008801179774A patent/CN101932557A/zh active Pending
- 2008-09-25 BR BRPI0817721-0A patent/BRPI0817721A2/pt not_active Application Discontinuation
- 2008-09-25 EP EP08836758A patent/EP2195287A1/en not_active Withdrawn
- 2008-09-25 KR KR1020107009323A patent/KR20100087300A/ko not_active Withdrawn
- 2008-09-25 MX MX2010003440A patent/MX2010003440A/es not_active Application Discontinuation
- 2008-09-25 US US12/677,846 patent/US20100305207A1/en not_active Abandoned
- 2008-09-25 AU AU2008309003A patent/AU2008309003A1/en not_active Abandoned
- 2008-09-25 JP JP2010527129A patent/JP2010540552A/ja active Pending
2010
- 2010-03-11 DO DO2010000075A patent/DOP2010000075A/es unknown
- 2010-03-26 ZA ZA2010/02181A patent/ZA201002181B/en unknown
- 2010-03-26 CO CO10036338A patent/CO6270306A2/es not_active Application Discontinuation
- 2010-04-14 MA MA32771A patent/MA31776B1/fr unknown
- 2010-04-28 CR CR11398A patent/CR11398A/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
ZA201002181B (en)	2011-06-29
KR20100087300A (ko)	2010-08-04
WO2009045830A1 (en)	2009-04-09
MX2010003440A (es)	2010-04-21
EP2195287A1 (en)	2010-06-16
DOP2010000075A (es)	2010-07-15
MA31776B1 (fr)	2010-10-01
CN101932557A (zh)	2010-12-29
US20100305207A1 (en)	2010-12-02
CR11398A (es)	2010-06-28
JP2010540552A (ja)	2010-12-24
CA2701120A1 (en)	2009-04-09
CO6270306A2 (es)	2011-04-20
EA201000391A1 (ru)	2010-10-29
AU2008309003A1 (en)	2009-04-09

Similar Documents

Publication	Publication Date	Title
BRPI0818533A2 (pt)	2017-06-06	composto, composição farmacêutica, e, processo para a preparação de um composto
BRPI0914927A2 (pt)	2017-06-20	composto, composição farmacêutica, métodos para inibir a função de fak e de tratamento de um câncer, uso de um composto, e, processo para preparar um composto
BRPI0817721A2 (pt)	2015-03-31	Composto, composição farmacêutica, método de tratamento, e, processo para preparação de um composto
BRPI0811275A2 (pt)	2014-12-23	Composto, processo para a preparação do mesmo, composição farmacêutica, uso de composto, e, método para tratar doença
BRPI0906786A2 (pt)	2015-07-14	Composto, processo para a preparação de um composto, uso de um composto, método para o tratamento de uma doença ou condição, composição farmacêutica, processo para a preparação de uma composição farmacêutica, produto, e, kit.
BR122020011920A2 (pt)	2020-08-25	composto, composição farmacêutica, método para tratar uma doença, uso de um composto, e processos para a preparação de um composto, e para a fabricação de um composto
BRPI0812851A2 (pt)	2014-09-30	Composto, composição farmacêutica, métodos para o tratamento de uma doença e de uma condição em um indivíduo, processo para preparar um composto, e, uso de um composto
BRPI0919488A2 (pt)	2015-12-01	composto, uso de um composto, método para tratar câncer em um animal de sangue quente, composição farmacêutica, e, processo para preparar um composto
BRPI0812521A2 (pt)	2015-06-23	Composto, composição farmacêutica, método para o tratamento de doença em um mamífero, processo para a preparação de um composto, e, uso de um composto
BRPI0909691A8 (pt)	2018-01-02	composto, método para preparar um composto, e, composição farmacêutica
BRPI1009022A2 (pt)	2016-03-08	"composto, composição farmacêutica, processo para produzir uma composição farmacêutica, uso de um composto, método para tratamento de uma doença ou transtorno e kit"
BRPI0815493A2 (pt)	2015-02-10	Composto, uso de um composto, composição faramcêutica, método para a terapia de dor, e, processo para preparar um composto.
BRPI0922475A2 (pt)	2017-06-06	composto, composição farmacêutica , método para tratar câncer, e, uso de um composto.
BRPI0718155A2 (pt)	2013-11-19	Composto, uso de um composto, método para tratar doenças mediadas por glk, e, processo para a preparação de um composto.
BR112012026843A2 (pt)	2016-07-12	composição, composição farmacêutica, processo para preparar uma composição farmacêutica, uso de uma composição e método para tratamento de hiv
BRPI0814163A2 (pt)	2015-01-20	Processo para a preparação de compostos, forma cristalina, e, composição farmacêutica
BRPI0816331A2 (pt)	2015-04-14	Composto, uso de um composto, composição farmacêutica, e, processo para preparar um composto.
BRPI0815784A2 (pt)	2015-02-24	Processo para a preparação de 1,2-propanodiol
BRPI0814821A2 (pt)	2015-02-03	Composto, composição farmacêutica, e, processo para preparar um composto
BRPI0922714A2 (pt)	2016-01-05	composto, processo para preparar um compsoto, medicamento, uso de um composto, e, composição farmacêutica
BR112013008008A2 (pt)	2016-06-21	composto, composição farmacêutica e processo para preparar um composto
BRPI0911897A2 (pt)	2015-07-28	Processo para a preparação de compostos, e, composto
BRPI0909198A2 (pt)	2019-09-24	composto antifolato, composto, método para preparar um composto antifolato, composição farmacêutica, método para tratar
BR112012016201A2 (pt)	2017-12-19	''composto, processo para a preparação de um composto, composição farmacêutica e uso de um composto''
BRPI1007654A2 (pt)	2016-02-23	composto, processo para a obtenção de um composto de fórmula geral e composição farmacêutica

Legal Events

Date	Code	Title	Description
2015-06-09	B11A	Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
2015-09-08	B11Y	Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired